Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NIH
Podcast
What’s ahead for biopharma and healthcare in 2026
Fierce reporters break down the forces that shaped biopharma and healthcare in 2025 and what lies ahead in 2026.
Ayla Ellison
,
Darren Incorvaia
,
Gabrielle Masson
,
Fraiser Kansteiner
,
Angus Liu
,
Eric Sagonowsky
,
Ben Adams
,
James Waldron
,
Heather Landi
,
Paige Minemyer
Dec 19, 2025 10:00am
A whirlwind week for pharma
Oct 3, 2025 9:00am
HHS, NIH, CDC leaders to steer revived vaccine safety panel
Aug 14, 2025 3:52pm
Angus on Angus: A Fierce oncology discussion
Apr 25, 2025 9:41am
New NIH research on talc use poses challenge to J&J
May 22, 2024 9:20am
Advocacy group activates Lung Force to push Congress for cash
Mar 19, 2024 1:11pm
